Fatty acid synthetase expression in triple-negative breast cancer
Background Triple-negative breast cancer (TNBC) has a relatively poor prognosis. Research has identified potential metabolic targets, including fatty acid metabolism, in TNBC. The absence of effective target therapies for TNBC led to exploration of the role of fatty acid synthetase (FASN) as a poten...
Saved in:
Main Authors: | Jin Hee Park (Author), Hye Seung Han (Author), So Dug Lim (Author), Wook Youn Kim (Author), Kyoung Sik Park (Author), Young Bum Yoo (Author), Seung Eun Lee (Author), Wan-Seop Kim (Author) |
---|---|
Format: | Book |
Published: |
Korean Society of Pathologists & the Korean Society for Cytopathology,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fatty liver associated with metabolic derangement in patients with chronic kidney disease: A controlled attenuation parameter study
by: Chang-Yun Yoon, et al.
Published: (2017) -
Association between p53 Expression and Amount of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
by: Miseon Lee, et al.
Published: (2019) -
No drug-drug interactions between selective prolyl‐tRNA synthetase inhibitor, bersiporocin, and pirfenidone or nintedanib in healthy participants
by: Wonsuk Shin, et al.
Published: (2024) -
Eradication Rates of Clarithromycin Triple Therapy in Korea: A Systematic Review and Meta-analysis
by: Seung Joo Kang, et al.
Published: (2021) -
Immunotherapy Treatment for Triple Negative Breast Cancer
by: Elizabeth R. Berger, et al.
Published: (2021)